News | Magnetic Resonance Imaging (MRI) | October 06, 2025

PULSE platform empowers Swoop system users worldwide to access advanced tools in support of imaging research and clinical studies in portable MRI.

 

Hyperfine Introduces Subscription-Based Platform to Accelerate Adoption of AI-Powered Portable MRI

Oct. 6, 2025 — Hyperfine, Inc. has launched the Portable Ultra-Low-Field Scientific Exchange (PULSE), a subscription-based platform designed to empower a global community of clinical researchers and developers advancing access and innovation in portable MRI.

Hyperfine is the developer of the first FDA-cleared AI-powered portable MRI system for the brain the Swoop system

Available to all Swoop AI-powered portable MRI system users, the PULSE subscription provides access to innovative tools that empower both clinical researchers and developers to advance the rapidly growing field of portable MRI. Subscribers gain access to proprietary Hyperfine research sequences powered by Optive AI software, can import and adapt community-developed sequences, and can access raw data to support diverse imaging initiatives. PULSE enables researchers to explore new clinical applications, while giving developers the foundation to prototype, test, and deploy next-generation imaging solutions. By bringing research capabilities into everyday clinical practice, PULSE enables research and innovation across specialties such as neurology, pediatrics, emergency medicine, neurosurgery, and underserved care.

“PULSE transforms the Swoop® system from a clinical device into an innovation platform,” said Maria Sainz, President and CEO of Hyperfine, Inc. “Through unprecedented access to our technology and collaborative support, we’re creating new opportunities for clinical researchers and developers to help advance the next wave of portable MRI technology. We look forward to partnering with PULSE subscribers to further accelerate the revolutionary potential of portable MRI.”

PULSE is now available via subscription to all Swoop system users. The platform includes a curated suite of tools as well as opportunities for advanced technical support. In future phases, Hyperfine plans to expand access to application developers without physical access to the Swoop® system, extending the impact of the program across academic institutions, startups, and AI innovators.

For more information about the Swoop system, please visit HyperfineMRI.com.


Related Content

News | Innovative Hospitals

May 27, 2026 — Nearly two years after announcing plans for a “real-world” academic-industrial collaboration, GE ...

Time June 03, 2026
arrow
News | Radiopharmaceuticals and Tracers

May 27, 2026 — Subtle Medical has received FDA clearance for its SubtleHD (PET), the company's next-generation AI ...

Time May 27, 2026
arrow
News | FDA

May 19, 2026 — DeepHealth has received the CE Mark for the Brain Health and Brain Age solutions within its Neuro Suite ...

Time May 26, 2026
arrow
News | Cardiac Imaging

May 21, 2026 — A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s ...

Time May 22, 2026
arrow
News | X-Ray

May 21, 2026 — RADIN Health and AZmed have announced the expansion of their strategic partnership and enhance radiology ...

Time May 22, 2026
arrow
News | Digital Pathology

May 7, 2026 — Roche has entered into a definitive merger agreement to acquire PathAI, a U.S.-based company in digital ...

Time May 21, 2026
arrow
News | Computed Tomography (CT)

May 12, 2026 – Bracco Imaging S.p.A. has purchased a mobile photon-counting CT scanner from MARS Bioimaging to support ...

Time May 20, 2026
arrow
Feature | Enterprise Imaging | Kyle Hardner

For radiology departments, the imbalance between surging imaging volume and a shortage of trained radiologists is taking ...

Time May 20, 2026
arrow
News | Radiology Imaging

May 18, 2026 — DICO, a company specializing in the creation of distributed diagnostic infrastructure for radiology, has ...

Time May 19, 2026
arrow
News | Interventional Radiology

May 12, 2026 — Siemens Healthineers has received clearance from the Food and Drug Administration for six new systems in ...

Time May 12, 2026
arrow
Subscribe Now